The Story of GLP-1. "The next really good idea". Episode 4

Thousands of years ago, it was good to have 'thriftiness' genes that enabled the body to preserve energy (calories) during cold winters. We are still equipped with these genes, but now they are really working against us by trying to preserve a body weight 'setpoint' that is too high in today's environment. This has caused obesity to spread epidemically throughout the world, driving cardio-metabolic disease (type 2 diabetes and cardio-vascular disease) to become the #1 killer globally. The race for an effective way to treat these diseases started in the 1990's with some important results for the GLP-1 hormone when given to animals and humans.
Follow “The next really good idea”, the last episode of the Novo Nordisk Foundation’s 2022 Advent Calendar “The Story of GLP-1”.”

[@VernCrisler]

Pretty cool stuff, and I'm sure in the next few years, if everyone works together and all ideas are heard, the GLP-1 and GIP activators will become even more effective and longer lasting. Bravo to Lotte and all the medical researchers in this modern day miracle story.

[@drnadolsky]

Incredible story! Thank you for putting this together.

[@HalloweenBEL]

Dr. Can you direct to where o can find this info in writing so I can appeal a medication coverage denial from my insurance company ???

[@HalloweenBEL]

Where can I find these documents so I can appeal a medication denial from my insurance?????